Literature DB >> 11481196

Off-label uses of modafinil.

E Teitelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11481196     DOI： 10.1176/ajp.158.8.1341

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Cognitive enhancement: methods, ethics, regulatory challenges.

Authors:  Nick Bostrom; Anders Sandberg
Journal:  Sci Eng Ethics       Date:  2009-06-19       Impact factor: 3.525

2.  Converging technologies: a critical analysis of cognitive enhancement for public policy application.

Authors:  Christos Makridis
Journal:  Sci Eng Ethics       Date:  2012-10-11       Impact factor: 3.525

3.  Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.

Authors:  Angela Rowland; Madelé van Dyk; David Warncken; Arduino A Mangoni; Michael J Sorich; Andrew Rowland
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335

4.  Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity.

Authors:  Nithiananda Chatterjie; James P Stables; Hsin Wang; George J Alexander
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 5.  The ethics of elective psychopharmacology.

Authors:  Ahmed D Mohamed; Barbara J Sahakian
Journal:  Int J Neuropsychopharmacol       Date:  2011-03-14       Impact factor: 5.176

6.  Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

Authors:  David B Arciniegas; C Alan Anderson; Jeannie Topkoff; Thomas W McAllister
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.